FiercePharma· @FiercePharma · X·· 26 天前AI 评分15
AI 导读
Martina Flammer 推动 brensocatib 从研发到获 FDA 批准，成为首个用于支气管扩张症的 DPP1 抑制剂。她是 2026 年 Fierce 50 突破奖得主。🔗https://www.fiercepharma.com/fierce-50/martina-flammer @Insmed #Fierce50
正文
Martina Flammer helped advance brensocatib from development through FDA approval as the first DPP1 inhibitor for bronchiectasis. She is a 2026 Fierce 50 Breakthrough honoree. 🔗https://www.fiercepharma.com/fierce-50/martina-flammer @Insmed #Fierce50
来源：FiercePharma · x.com